| Literature DB >> 30033340 |
Xiaofeng Dai1, Kateryna Bazaka2, Derek J Richard3, Erik Rik W Thompson4, Kostya Ken Ostrikov2.
Abstract
Atmospheric pressure gas plasmas are emerging as a promising treatment in cancer that can supplement the existing set of treatment modalities and, when combined with other therapies, enhance their selectivity and efficacy against resistant cancers. With further optimisation in production and administration of plasma treatment, plasma-enabled therapy has a strong potential to mature as a tool for selectively curing highly resistant solid tumours. Although intense preclinical studies have been conducted to exploit the unique traits of plasma as an oncotherapy, few clinical studies are underway. This review identifies types of cancers and patient groups that most likely benefit from plasma oncotherapy, to introduce clinical practitioners to plasma therapy and accelerate the speed of translating plasma for cancer control in clinics.Entities:
Keywords: chemotherapy; cold atmospheric plasma; multimodality therapy; oncotherapy; radiotherapy
Mesh:
Substances:
Year: 2018 PMID: 30033340 DOI: 10.1016/j.tibtech.2018.06.010
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536